TranspariMED: Europäische Arzneimittel-Agentur ergreift rasche Maßnahmen bei fehlenden Ergebnissen klinischer Studien – Europäische AIDS-Behandlungsgruppe

Vollstaendiger Artikelinhalt

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

The European Medicines Agency (EMA) has taken rapid and decisive initial steps to ensure that clinical trial results are made public as required by law. In a letter sent in response to a recent call by 20 health groups for EMA to address the problem, the agency disclosed that it has already: By the end of the year, EMA will additionally publicly report on the number of published clinical trial results. Related HIV and Co-Infections News July 10,2026GENDER: Challenging inequalities: HIV, age, gender, and the dynamics of intrasectionality July 10,2026JAMA: HIV may hide in more cells than previously thought — here’s what that could mean for a cure July 8,2026La Jolla Institute for Immunology: New HIV vaccine shows unprecedented success in preclinical study Started sending out email notifications to companies and universities when trial results become due Set up a monitoring system that shows national regulators which of their trials have failed to report results GENDER: Challenging inequalities: HIV, age, gender, and the dynamics of intrasectionality JAMA: HIV may hide in more cells than previously thought — here’s what that could mean for a cure La Jolla Institute for Immunology: New HIV vaccine shows unprecedented success in preclinical study